Serum VEGF and bFGF in patients with inflammatory bowel diseases


COD: 03_2014_203-206 Categorie: ,

Nikolaos Kopanakis, Athanasia Saiti, Efthimios D’Avgerinos, Kiriaki Masselou, Maria Simiri, Aikaterini Mandaraka, Georgios Vasiliadis, Vaggelogiannis Katergiannakis

Ann. Ital. Chir., 2014 85: 203-206

La mia nuova descrizione qui!

Price of a print issue €25.00

AIM: The role of angiogenesis in inflammatory bowel diseases (IBD) remains controversial. We investigated the role of
serum concentration levels of VEGF and bFGF in IBD patients and assessed their potential association to disease activity.
Patients and Methods: Blood samples were obtained from 40 IBD patients with moderate to severe attack of the
disease and 40 healthy controls. VEGF andbFGF serum levels were assessed. C-reactive protein (CRP) and erythrocyte
sedimentation rate (ESR) were measured as markers of disease activity and correlated to VEGF and bFGF.
RESULTS: The demographic characteristics of both patients and controls were homogenous, in regard of age, sex, smoke
and concomitant diseases. VEGF serum levels were significantly higher in IBD patients compared to controls (1158.5±845.4
pg/ml vs 464.6±283.1 pg/ml, p<0.001). Serum concentration levels of bFGF did not differ between groups. Linear regression analysis showed no direct association between VEGF or bFGF and CRP or ESR. CONCLUSION: VEGF, but not bFGF, may have a prominent role in patients with IBD, without though direct association to disease activity.